跳至主要内容
临床试验/ISRCTN31662931
ISRCTN31662931进行中(未招募)未知

Predicting response to progestins for the treatment of endometrial hyperplasia and endometrioid adenocarcinoma of the endometrium

Central Manchester University Hospitals NHS Trust (CMFT) (UK)0 个研究点目标入组 150 人开始时间: 2014年6月12日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Age 18 or more
  • 2. Attending the gynaecological outpatient clinic at St Mary?s Hospital
  • 3. Biopsy-proven well differentiated endometrioid adenocarcinoma of the endometrium (EC) with no myometrial invasion and/or endometrial hyperplasia (EH)
  • 4. Clinical decision to treat EH or EC with progestins
  • 5. Written, informed consent to take part in the study; Target Gender: Female

排除标准

  • 1. Non endometrioid or mixed histology or concerning histological features
  • 2. Myometrial invasion on imaging
  • 3. Progestin therapy contraindicated
  • 4. Unable to sample endometrium pre/post progestin therapy

研究者

发起方
Central Manchester University Hospitals NHS Trust (CMFT) (UK)

相似试验